Promotions & Moves

Bioclinica Appoints CEO

Hubbard to retire, Herron assumes role of CEO

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

David Herron has been appointed chief executive officer of Bioclinica, effective January 2, 2018. This follows the planned retirement of current chief executive officer, John Hubbard, Ph.D., who will remain as a non-executive director on the Bioclinica board. Mr. Herron has more than 10 years of experience at Bioclinica leading the company’s Medical Imaging business, where he integrated three of the industry’s leading medical imaging companies (Bioclinica, Corelab Partners, and Synarc) into o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters